BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5287100)

  • 1. Glucose tolerance, plasma insulin and lipids in postmenopausal women during sequential oestrogen-progestin treatment.
    Pyörälä K; Pyörälä T; Lampinen V; Taskinen MR
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:28. PubMed ID: 5287100
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary experiences with a sequential preparation in the treatment of menopausal complaints.
    Schellen AM; Branolte JH
    Bull Soc R Belge Gynecol Obstet; 1969; 39(3):203-9. PubMed ID: 5399681
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with a sequential oral contraceptive].
    Buus JG
    Ugeskr Laeger; 1970 Dec; 132(52):2477-80. PubMed ID: 5491497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of an oral gestagen, Sapilon].
    Murai ; Okada M; Obarasawa H; Osawa S; Aida R
    Sanfujinka No Jissai; 1969 Sep; 18(9):874-8. PubMed ID: 5394771
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic effects of a sequential regimen.
    Spain WT
    Int J Fertil; 1968; 13(4):431-5. PubMed ID: 5700402
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose and insulin levels during treatment with a combined oral contraceptive agent.
    Larsson-Cohn U
    Acta Soc Med Ups; 1971; 76(5-6):223-7. PubMed ID: 5141078
    [No Abstract]   [Full Text] [Related]  

  • 8. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma cortisol after one to sixty cycles of oral contraception.
    Williamson HO; Moody LO
    J Reprod Med; 1970 Jul; 5(1):9-12. PubMed ID: 5521772
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraception using a sequential method. A clinical investigation.
    Stenström B
    Acta Obstet Gynecol Scand; 1968; 47(4):443-50. PubMed ID: 4890970
    [No Abstract]   [Full Text] [Related]  

  • 11. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.
    Otsuki M; Kasayama S; Morita S; Asanuma N; Saito H; Mukai M; Koga M
    Menopause; 2007; 14(3 Pt 1):404-7. PubMed ID: 17213751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of ethinyl estradiol on glucose metabolism in postmenopausal women].
    Wu J; Bi Y; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Sep; 32(9):528-31. PubMed ID: 9639751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new type of oral contraceptive.
    McBride W
    Med J Aust; 1970 Jan; 1(5):212-5. PubMed ID: 4908221
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
    Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
    Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
    Signorelli I; Emanueli A
    Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and biochemical effects of megestrol acetate allone and two megestrol acetate-estrogen combinations in gynecological indications].
    Arnold M; Richter RH; Roth F
    Z Geburtshilfe Gynakol; 1969 Oct; 171(2):125-44. PubMed ID: 5355553
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical research on a new progestagen (norgestrel) combined with ethinyl estradiol].
    Murray E; Bosch LR; Lema BE
    Prensa Med Argent; 1970 Oct; 57(31):1485-94. PubMed ID: 5485488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
    Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
    Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ageing on prednisone-glucose tolerance and serum lipids.
    Jakobson T; Kahanpää A
    Ann Med Intern Fenn; 1968; 57(1):9-14. PubMed ID: 5726765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.